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Introduction
Invasive non-typhoidal Salmonella (iNTS) disease is princi-
pally caused by serovars S. Typhimurium and S. Enteritidis and 
is thought to be responsible for up to 680,000 deaths annually, 
with Africa accounting for more than half of cases1. Much of this 
burden is in children under 5 years and HIV-infected adults. 
In view of this major global burden of disease, and rapid 
emergence of multidrug resistant iNTS strains2, development 
of a vaccine is increasingly vital3.
Studies in Malawian children indicate that anti-S. Typhimu-
rium antibodies, notably IgG to O-antigen of LPS and flagellin, 
and serum bactericidal activity rises rapidly with age in the first 
few years of life corresponding with a fall in cases of iNTS 
disease4,5. One study found a positive correlation between serum 
bactericidal assay (SBA) killing and acquisition of anti-LPS 
IgG5. However, there is no standardised assay for measurement 
of iNTS-specific IgG, and the clinical significance of the iNTS 
SBA is unknown. Given that incidence of iNTS disease drops 
in children over 2 years, it has been suggested that a rise in spe-
cific antibodies and bactericidal activity correlates with protec-
tion. This hypothesis is complicated by the observation that 
among HIV-infected Malawian adults, high LPS-specific IgG 
was associated with a lack of in vitro bacterial killing6.
Methods
In a cross-sectional study, we investigated NTS-specific anti-
body responses in the rural Ugandan General Population Cohort 
(GPC)7. Levels of IgG against serovars S. Typhimurium and 
S. Enteritidis LPS O-antigens were measured using a stand-
ardised in-house ELISA in stored sera from a cross-section of 
1,090 Ugandans of all ages, 10 of whom were HIV-infected. 
Sera from adults (≥ 16 years) were collected from January 2014 
to November 2015, and children (<16 years) from January 
2016 to November 2017. Antibody units (AU) were calculated 
using Gen5 software (version 2.0) using a five-parameter logis-
tic (5PL) curve generated with a standard serum from an 
iNTS-exposed individual. Sera were defined as seronegative 
if below the lower limit of detection (4 AU for S. Typhimurium 
and 5 AU for S. Enteritidis) at 1:100 serum dilution.
Written informed consent for the use of clinical records and bio-
logical samples for research purposes was obtained from all 
GPC participants following Uganda National Council of Sci-
ence and Technology guidelines. Ethical approval for the use of 
samples for this study was obtained from The UVRI Research 
and Ethics Committee and from the Uganda Council for Science 
and Technology (Ref: GC/127/19/10/710).
Results and discussion
In this assay, overall O-antigen seropositivity was 82% for 
S. Typhimurium, and was 70% for S. Enteritidis. Levels of anti-
body were undetectable in at least 50% of children until 18 months 
for both serovars and a similar pattern of increasing IgG level was 
observed with increasing age (Figure 1A, B). There were no 
observable differences in antibody levels by sex (Figure 1C, D). 
HIV-infected individuals did not have notably high IgG antibody 
responses, although the study was not powered to demonstrate this.
Figure 1. Plots showing antibody units (AU) for S. Typhimurium (A and C) and S. Enteritidis (B and D) by age. Orange dots indicate HIV 
infected individuals. (A, B). Females are indicated in red and males in blue  (C, D). The box shows the interquartile range (IQR) with middle 
line representing the median. The whiskers represent the adjacent values, defined as 1.5 × IQR from the edge of the box, with values outside 
this range shown individually. LLOQ, lower limit of quantification.
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Although performed using a flow cytometric assay, previously 
published data from Malawi suggest that NTS-specific IgG is 
present in the majority of children throughout infancy4, contrast-
ing with our results from Uganda. This could be due to variation 
in exposure to iNTS in Uganda compared to Malawi, or differ-
ences in assays. However, burden of, and exposure to, iNTS dis-
ease in Uganda is not well understood. A standardised assay 
is key to understanding variation in exposure across geographic 
locations to support vaccine development.
Data availability
Open Science Framework: Invasive Non-Typhoidal Salmonella 
serology in Uganda. https://doi.org/10.17605/OSF.IO/68BYT8.
This project contains the age, sex, antibody levels, HIV status 
and Salmonella status of each participant.
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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